discu
Newsletters
Mentions
Extension
Pricing
Login
Sign Up
Reddit
Novo Nordisk study finds that semaglutide (Wegovy) reduces risk of serious cardiovascular events such as heart attacks by 20% in overweight patients with a history of cardiovascular disease and no history of diabetes
https://www.nejm.org/doi/full/10.1056/NEJMoa2307563
230 comments
11/11/2023
science